高级检索
当前位置: 首页 > 详情页

TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Department of Biliary-Pancreatic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China [2]Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China [3]Institute of Integrated Traditional Chinese and Western Medicine Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China [4]Department of Plastic and Cosmetic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China
出处:
ISSN:

关键词: cancer ferroptosis FSP1 TRIM21 ubiquitination

摘要:
Ferroptosis, an iron-dependent form of regulated cell death driven by excessive accumulation of lipid peroxides, has become a promising strategy in cancer treatment. Cancer cells exploit antioxidant proteins, including Ferroptosis Suppressor Protein 1 (FSP1), to prevent ferroptosis. In this study, it is found that the E3 ubiquitin ligase TRIM21 bound to FSP1 and mediated its ubiquitination on K322 and K366 residues via K63 linkage, which is essential for its membrane translocation and ferroptosis suppression ability. It is further verified the protective role of the TRIM21-FSP1 axis in RSL3-induced ferroptosis in cancer cells and a subcutaneous tumor model. Moreover, TRIM21 is highly expressed in multiple gastrointestinal (GI) tumors, and its expression is further stimulated upon ferroptosis induction in cancer cells and the KPC mouse model. In summary, This study identifies TRIM21 as a negative regulator of ferroptosis through K63 ubiquitination of FSP1, which can serve as a therapeutic target to enhance the chemosensitivity of tumors based on ferroptosis induction.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 材料科学
小类 | 1 区 材料科学:综合 1 区 化学:综合 1 区 纳米科技
最新[2025]版:
大类 | 1 区 综合性期刊
小类 | 1 区 化学:综合 1 区 材料科学:综合 1 区 纳米科技
JCR分区:
出版当年[2021]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY Q1 NANOSCIENCE & NANOTECHNOLOGY
最新[2023]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY Q1 NANOSCIENCE & NANOTECHNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者单位: [1]Department of Biliary-Pancreatic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China [2]Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Biliary-Pancreatic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China [2]Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:432 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)